Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.29 | 0.17 | 0.47 | 0.10 | 0.05 | 0.10 | 0.25 | 11.71 | 108.59 | 174.09 | 279.41 | 0.00 |
| Expenses | 0.03 | 0.11 | 0.71 | 0.07 | 0.08 | 0.14 | 0.16 | 11.62 | 106.79 | 173.32 | 279.78 | 0.18 |
| Operating Profit | 0.26 | 0.06 | -0.24 | 0.03 | -0.03 | -0.04 | 0.09 | 0.09 | 1.80 | 0.77 | -0.37 | -0.18 |
| OPM % | 89.66% | 35.29% | -51.06% | 30.00% | -60.00% | -40.00% | 36.00% | 0.77% | 1.66% | 0.44% | -0.13% | |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.26 | 0.06 | -0.24 | 0.03 | -0.03 | -0.02 | 0.07 | 0.09 | 1.80 | 0.77 | -0.37 | -0.18 |
| Tax % | 0.00% | 0.00% | -4.17% | 0.00% | 33.33% | 0.00% | 0.00% | 0.00% | 26.11% | 25.97% | 27.03% | 0.00% |
| Net Profit | 0.26 | 0.06 | -0.23 | 0.02 | -0.04 | -0.02 | 0.06 | 0.09 | 1.32 | 0.57 | -0.48 | -0.18 |
| EPS in Rs | 0.48 | 0.11 | -0.42 | 0.04 | -0.07 | -0.04 | 0.11 | 0.16 | 2.41 | 1.04 | -0.88 | -0.33 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 574 | 562 |
| Expenses | 0 | 0 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 572 | 560 |
| Operating Profit | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 2 | 2 |
| OPM % | -5% | 10% | -1.3% | -31% | 2.0% | 2.0% | -1.0% | -7% | 2.6% | 20% | 0.4% | 0.4% |
| Other Income | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 2 | 2 |
| Tax % | 0% | 0% | 0% | 0% | 20% | 0% | 50% | 0% | -50% | 40% | 34% | |
| Net Profit | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 2 | 1 |
| EPS in Rs | -0.02 | 0.05 | -0.29 | -0.02 | 0.05 | 0.02 | -0.07 | -0.15 | 0.05 | 0.05 | 2.76 | 2.24 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 122% | 311% | 691% | 4542% | ||
| Compounded Profit Growth | 65% | 173% | 175% | 1267% | ||
| Stock Price CAGR | % | 54% | 85% | -31% | ||
| Return on Equity | 9% | 10% | 12% | 13% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | 18 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 313 |
| Total Liabilities | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 343 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 343 |
| Total Assets | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 343 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0 | -0 | 0 | 0 | -0 | 0 | 1 | -0 | 0 | 0 | 0 | -28 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Cash from Financing Activity | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 28 |
| Net Cash Flow | -0 | -0 | 0 | 0 | -0 | -0 | 1 | -0 | 0 | -0 | 0 | 0 |
| Free Cash Flow | -0 | -0 | 0 | 0 | -0 | 0 | 1 | -0 | 0 | -0 | 0 | -28 |
| CFO/OP | 114% | 100% | 133% | -600% | 17% | 650% | 5,200% | 2,450% | -12% | 0% | 190% | -1,223% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 24 | 54 | 179 | 107 | 164 | 122 | 135 | 229 | 212 | 215 | |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||
| Days Payable | 197 | |||||||||||
| Cash Conversion Cycle | 36 | 24 | 54 | 179 | 107 | 164 | 122 | 135 | 229 | 212 | 19 | |
| Working Capital Days | 18 | -35 | 36 | 260 | 221 | 60 | 98 | 129 | 145 | 387 | 15 | |
| ROCE % | -3% | -3% | 7% | 25% | -31% | 3% | 2% | -3% | -13% | 3% | 17% | 15% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.85% | 10.86% | 10.86% | 10.71% | 8.59% | 11.15% |
| Public | 100.00% | 100.00% | 100.00% | 100.00% | 99.99% | 100.00% | 89.14% | 89.15% | 89.14% | 89.29% | 91.40% | 88.85% |
| No. of Shareholders | 1,712 | 1,722 | 1,981 | 2,039 | 2,073 | 2,123 | 2,204 | 2,277 | 2,416 | 2,396 | 2,457 | 2,430 |
Fundamentals
Market Cap₹ 17.1 Cr.
Current Price₹ 31.2
Stock P/E13.9
Book Value₹ 42.5
ROCE15.0 %
ROE12.7 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)4542%
Compounded Profit Growth (TTM)1267%
Standalone figures.
Valuation
Market capRs 17 Cr
Enterprise valueRs 24 Cr
P/E (TTM)14.17x
Price to book0.75x
Price to sales0.03x
EV / EBITDA11.92x
EV / EBIT11.92x
EV / sales0.04x
Earnings yield7.06%
P/E, 3-year average143.41x
P/B, 3-year average7.93x
P/E, 5-year average143.41x
P/B, 5-year average6.32x
Profitability
Operating margin (excl. other income)0.40%
Operating margin (incl. other income)0.40%
EBITDA margin0.35%
Pre-tax margin0.35%
Net profit margin0.21%
ROE12.69%
ROCE15.00%
ROA0.88%
ROE, 3-year average7.99%
ROCE, 3-year average9.18%
ROA, 3-year average2.82%
ROE, 5-year average0.56%
ROCE, 5-year average2.29%
ROA, 5-year average-1.34%
ROIC (approx.)4.46%
Tax rate34.06%
Growth
Sales growth (latest year)114662.00%
Profit growth (latest year)4933.33%
Sales CAGR, 3 years690.87%
Sales CAGR, 5 years310.88%
Profit CAGR, 5 years172.77%
Profit growth YoY (latest quarter)-300.00%
Per share
EPS (TTM)Rs 2.25
EPS (latest year)Rs 2.76
EPS (latest quarter)Rs -0.33
EPS, 3-year averageRs 0.96
EPS, 5-year averageRs 0.53
Book value per shareRs 42.48
Sales per shareRs 1,049.34
Cash flow per shareRs -51.22
Free cash flow per shareRs -51.20
Efficiency
Asset turnover1.67x
Fixed asset turnover28690.50x
Inventory turnover517.49x
Inventory days1 days
Debtor days215 days
Debtors turnover1.70x
Creditor days197 days
Cash conversion cycle19 days
Working capital days15 days
Leverage
Total debtRs 7 Cr
Cash and bankRs 0 Cr
Net debtRs 7 Cr
Debt to equity0.29x
Net debt / EBITDA3.29x
Owners' fund to total sources6.77%
Debt to assets1.97%
Cash flow
Cash from Operating Activity (latest year)Rs -28 Cr
Cash from Investing Activity (latest year)Rs 0 Cr
Cash from Financing Activity (latest year)Rs 28 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -28 Cr
Cash from ops / profit, 5 years-14.00x
Statement figures
Net sales (TTM)Rs 574 Cr
Net sales (latest year)Rs 574 Cr
Operating profit excl. other income (latest year)Rs 2 Cr
Operating profit (latest quarter)Rs -0 Cr
EBITDA (TTM)Rs 2 Cr
PBDT (TTM)Rs 2 Cr
Profit before tax (TTM)Rs 2 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 2 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 569 Cr
Total expenditure (latest year)Rs 572 Cr
Total income (latest year)Rs 574 Cr
Share capitalRs 5 Cr
ReservesRs 18 Cr
Shareholders' fundsRs 23 Cr
Total assetsRs 343 Cr
Net blockRs 0 Cr
ReceivablesRs 338 Cr
InventoryRs 1 Cr
Other liabilitiesRs 313 Cr
Shares outstanding (crore)0.55
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 14.2 is at the 9th percentile of its own 4.7-year range
(median 58.7, low 12.2, high 288.9).
P/B 0.75 is at the 1th percentile (median 3.61).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 531099 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -0.4% | -2.8% | +2.4 pts |
| 1 month | -16.1% | -6.8% | -9.3 pts |
| 3 months | -17.7% | -7.6% | -10.1 pts |
| 3 years | +513.1% | +14.2% | +498.9 pts |
| 5 years | +738.9% | +27.9% | +711.1 pts |
Red flags
F-score 3 of 8| explain | Receivables outrunning sales Receivables grew 116359% vs sales +114662% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr -100.0% vs Jun 2025.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Centuple Global Ltd?
Centuple Global Ltd (531099) has a market capitalisation of Rs 17.1 Cr. at the 2026-10-01 close.
What is the P/E ratio of Centuple Global Ltd?
Centuple Global Ltd trades at a P/E of 13.9 on trailing twelve-month profit, at the 2026-10-01 close.
What were Centuple Global Ltd's latest quarterly results?
In the Jun 2026 quarter, Centuple Global Ltd sales was Rs 0 Cr (-100.0% vs Jun 2025) with a net loss of Rs 0 Cr.